VACBF (Nykode Therapeutics AS) Marketable Securities : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Nykode Therapeutics AS's Marketable Securities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Nykode Therapeutics AS's annual Marketable Securities declined from Dec. 2021 ($12.17 Mil) to Dec. 2022 ($0.00 Mil) but then stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Nykode Therapeutics AS Marketable Securities Historical Data

The historical data trend for Nykode Therapeutics AS's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Marketable Securities Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

21.68

24.94

12.17

Nykode Therapeutics AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Nykode Therapeutics AS Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Nykode Therapeutics AS (OTCPK:VACBF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Nykode Therapeutics AS Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.